S&P 500
(0.95%) 5 096.24 points
Dow Jones
(0.22%) 38 169 points
Nasdaq
(1.90%) 15 909 points
Oil
(0.06%) $83.62
Gas
(-1.71%) $1.610
Gold
(0.17%) $2 346.50
Silver
(-0.34%) $27.26
Platinum
(0.40%) $924.20
USD/EUR
(0.52%) $0.937
USD/NOK
(0.85%) $11.04
USD/GBP
(0.47%) $0.803
USD/RUB
(-0.13%) $92.05

Realtime updates for Sosei Group Corporation [4565.T]

Exchange: JPX Sector: Healthcare Industry: Biotechnology
Last Updated26 Apr 2024 @ 02:15

-2.47% ¥ 1 458.00

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 02:15):

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis...

Stats
Today's Volume 3.09M
Average Volume 1.31M
Market Cap 130.41B
EPS ¥-2.13 ( 2024-02-13 )
Next earnings date ( ¥35.75 ) 2024-05-08
Last Dividend ¥2.50 ( 2015-03-27 )
Next Dividend ¥0 ( N/A )
P/E -16.73
ATR14 ¥1.209 (0.08%)

Volume Correlation

Long: -0.23 (neutral)
Short: 0.92 (very strong)
Signal:(52.676) Expect same movement, but be aware

Sosei Group Corporation Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sosei Group Corporation Correlation - Currency/Commodity

The country flag 0.29
( neutral )
The country flag 0.35
( neutral )
The country flag 0.48
( neutral )
The country flag 0.27
( neutral )
The country flag 0.38
( neutral )
The country flag 0.40
( neutral )

Sosei Group Corporation Financials

Annual 2023
Revenue: ¥12.77B
Gross Profit: ¥7.87B (61.62 %)
EPS: ¥-87.17
FY 2023
Revenue: ¥12.77B
Gross Profit: ¥7.87B (61.62 %)
EPS: ¥-87.17
FY 2022
Revenue: ¥15.57B
Gross Profit: ¥14.64B (94.05 %)
EPS: ¥4.67
FY 2021
Revenue: ¥17.71B
Gross Profit: ¥16.78B (94.73 %)
EPS: ¥12.53

Financial Reports:

No articles found.

Sosei Group Corporation Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

Sosei Group Corporation Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend ¥2.50 2015-03-27
Last Dividend ¥2.50 2015-03-27
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out ¥2.50 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-04-26)
¥0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
8308.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
7705.T Ex Dividend Knight 2024-03-28 Annually 0 0.00%
6861.T Ex Dividend Knight 2023-09-19 Semi-Annually 0 0.00%
6237.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
4958.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
4116.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
3349.T Ex Dividend Knight 2023-11-29 Semi-Annually 0 0.00%
2427.T Ex Dividend Junior 2023-12-28 Annually 0 0.00%
9351.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
8053.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.5631.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.04581.200-1.525-1.830[0 - 0.3]
returnOnEquityTTM-0.1171.500-2.41-3.62[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.790.80010.008.00[1 - 3]
quickRatioTTM3.570.80010.008.00[0.8 - 2.5]
cashRatioTTM2.861.50010.0010.00[0.2 - 2]
debtRatioTTM0.445-1.5002.58-3.87[0 - 0.6]
interestCoverageTTM-3.341.000-2.35-2.35[3 - 30]
operatingCashFlowPerShareTTM-58.952.00-10.00-10.00[0 - 30]
freeCashFlowPerShareTTM-68.472.00-10.00-10.00[0 - 20]
debtEquityRatioTTM1.048-1.5005.81-8.71[0 - 2.5]
grossProfitMarginTTM0.6971.0001.7231.723[0.2 - 0.8]
operatingProfitMarginTTM-0.6921.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.07531.000-1.530-1.530[0.2 - 2]
assetTurnoverTTM0.08120.800-2.79-2.23[0.5 - 2]
Total Score-1.525

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-18.121.000-1.9310[1 - 100]
returnOnEquityTTM-0.1172.50-1.551-3.62[0.1 - 1.5]
freeCashFlowPerShareTTM-68.472.00-10.00-10.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-58.952.00-10.00-10.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.2891.500-1.4080[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.4131.000-10.000[0.1 - 0.5]
Total Score-3.79

Sosei Group Corporation

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators